Sanofi (SNYNF)
96.81
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Sanofi Enterprise Value : 126.76B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 126.76B |
| November 12, 2026 | 126.76B |
| November 11, 2026 | 126.08B |
| November 10, 2026 | 126.08B |
| November 09, 2026 | 126.08B |
| November 06, 2026 | 124.01B |
| November 05, 2026 | 124.46B |
| November 04, 2026 | 120.46B |
| November 03, 2026 | 119.46B |
| November 02, 2026 | 120.36B |
| October 30, 2026 | 118.76B |
| October 29, 2026 | 110.14B |
| October 28, 2026 | 109.60B |
| October 27, 2026 | 110.51B |
| October 26, 2026 | 112.20B |
| October 23, 2026 | 108.35B |
| October 22, 2026 | 108.35B |
| October 21, 2026 | 109.15B |
| October 20, 2026 | 106.63B |
| October 19, 2026 | 104.50B |
| October 16, 2026 | 104.59B |
| October 15, 2026 | 104.59B |
| October 14, 2026 | 104.13B |
| October 13, 2026 | 102.42B |
| October 12, 2026 | 106.35B |
| Date | Value |
|---|---|
| October 09, 2026 | 105.12B |
| October 08, 2026 | 106.27B |
| October 07, 2026 | 104.24B |
| October 06, 2026 | 103.29B |
| October 05, 2026 | 104.52B |
| October 02, 2026 | 103.89B |
| October 01, 2026 | 106.77B |
| September 30, 2026 | 107.28B |
| September 29, 2026 | 106.56B |
| September 28, 2026 | 107.45B |
| September 25, 2026 | 106.30B |
| September 24, 2026 | 108.43B |
| September 23, 2026 | 107.47B |
| September 22, 2026 | 109.77B |
| September 21, 2026 | 112.85B |
| September 18, 2026 | 111.08B |
| September 17, 2026 | 113.03B |
| September 16, 2026 | 113.03B |
| September 15, 2026 | 113.03B |
| September 14, 2026 | 113.03B |
| September 11, 2026 | 111.23B |
| September 10, 2026 | 115.23B |
| September 09, 2026 | 112.44B |
| September 08, 2026 | 114.97B |
| September 04, 2026 | 117.61B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 598.40B |
| GSK Plc | 128.16B |
| Novartis AG | 342.80B |
| Pfizer Inc. | 213.37B |
| Roche Holding AG | -- |
Enterprise Value Related Metrics
| Earnings Yield | 4.01% |
| Operating Earnings Yield | 12.42% |
| Normalized Earnings Yield | 7.097 |